BIODESIX INC — Director's Dealing 2024

Nov 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2024-11-21

Reporting Person: Kennedy Lawrence T. Jr (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-21	Common Stock	P	35000	$1.1589	Acquired	10411024	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12267873	Indirect
Common Stock	2775386	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.155 to $1.1602, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.